N/A
Manufactured by NARS Cosmetics
6 FDA adverse event reports analyzed
Last updated: 2026-04-15
OCTINOXATE, TITANIUM DIOXIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by NARS Cosmetics. The most commonly reported adverse reactions for OCTINOXATE, TITANIUM DIOXIDE include EMOTIONAL DISTRESS, HYPERAESTHESIA, PRODUCT FORMULATION ISSUE, RASH, SELF ESTEEM DECREASED. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for OCTINOXATE, TITANIUM DIOXIDE.
Out of 1 classified reports for OCTINOXATE, TITANIUM DIOXIDE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 6 FDA FAERS reports that mention OCTINOXATE, TITANIUM DIOXIDE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include EMOTIONAL DISTRESS, HYPERAESTHESIA, PRODUCT FORMULATION ISSUE, RASH, SELF ESTEEM DECREASED, SKIN IRRITATION. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list NARS Cosmetics in connection with OCTINOXATE, TITANIUM DIOXIDE. Always verify the specific product and NDC with your pharmacist.